Physician
Cumberland Valley Retina Consultants PC
Cumberland Valley Retina Consultants PC was paid $10.25M by Medicaid between Jan 2018 and Dec 2024, across 23 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 34% of everything it billed.
33Billing provider infoCUMBERLAND VALLEY RETINA CONSULTANTS PC
HAGERSTOWN, MD 21740
HAGERSTOWN, MD 21740
33aNPI1467429647assigned 03/07/2006
33bProvider typeOphthalmology Physician
28Total paid$10.25M
24GClaims82,100
24DCodes billed23
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Maryland
Rank by total paid#1 of 124
Median peer was paid$19K
This provider vs. median535×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,281 | $133K | |
| 2019 | 2,766 | $128K | |
| 2020 | 7,538 | $1.41M | |
| 2021 | 14,334 | $2.26M | |
| 2022 | 16,743 | $2.02M | |
| 2023 | 19,950 | $2.26M | |
| 2024incomplete | 18,488 | $2.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 34% | 3,375 | 2,489 | $3.50M |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 22% | 2,386 | 1,848 | $2.24M |
| J2778 | Injection, ranibizumab, 0.1 mg | 14% | 3,369 | 2,698 | $1.48M |
| 92134 | 7.6% | 21,329 | 18,542 | $778K | |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 6.4% | 3,148 | 2,466 | $655K |
| 67028 | Intravitreal injection of a pharmacologic agent | 6.0% | 15,946 | 12,176 | $612K |
| 92201 | 1.8% | 9,461 | 8,721 | $183K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 4,264 | 3,957 | $176K |
| 76512 | 1.4% | 3,993 | 2,545 | $140K | |
| 92250 | <1% | 3,233 | 2,840 | $99K | |
| 92235 | <1% | 2,349 | 2,165 | $95K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 3,416 | 2,766 | $84K |
11 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 751 | $62K |
| 92020 | <1% | 1,770 | $55K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 801 | $33K |
| 92060 | <1% | 759 | $23K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 632 | $22K |
| J3490 | Unclassified drugs | <1% | 17 | $7K |
| 92226 | <1% | 726 | $6K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 29 | $3K |
| 92242 | <1% | 48 | $2K | |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | <1% | 278 | $2K |
| 92202 | <1% | 20 | $217.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHU, ALLEN (PRESIDENT)